Волшебная пилюля? Дайте две!
Волшебная пилюля? Дайте две!
32. Mozaffarian D. Fish oil: Physiologic effects and administration. UpToDate. 2020 (https://www.uptodate.com/contents/fish-oil-physiologic-effects-and-administration).
Fish oil: Physiologic effects and administration.
33. Greenberg P. Fool’s gold: what fish oil is doing to our health and the planet. The Guardian. 2018 (https://www.theguardian.com/lifeandstyle/2018/jul/25/fish-oil-hype-health-planet-supplements-study-no-benefit).
Fool’s gold: what fish oil is doing to our health and the planet.
34. Mikulic M. Global omega-3 supplement market size 2016 vs. 2025. Statista. 2017 (https://www.statista.com/statistics/758383/omega-3-supplement-market-size-worldwide/#statisticContainer).
Global omega-3 supplement market size 2016 vs. 2025.
35. Мотова Е. Говорят, для здоровья нужно принимать омегу-3. Правда? Meduza. 2020 (https://meduza.io/cards/govoryat-dlya-zdorovya-nuzhno-prinimat-omegu-3-pravda).
Говорят, для здоровья нужно принимать омегу-3. Правда?
36. Omega-3 Fatty Acids. NIH. 2019 (https://ods.od.nih.gov/factsheets/Omega3Fat-tyAcids-HealthProfessional/).
Omega-3 Fatty Acids.
37. Kwak S. M., Myung S. K., Lee Y. J., Seo H. G. Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Archives of internal medicine. 2012; 172(9): 686-694.
Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.
38. Chowdhury R., Stevens S., Gorman D. et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ. 2012; 345: e6698.
Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis.
39. Aung T., Halsey J., Kromhout D. et al. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. JAMA cardiology. 2018; 3(3): 225-234.
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
40. Chowdhury R., Warnakula S., Kunutsor S. et al. Association of dietary, circulating and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Annals of internal medicine. 2014; 160(6): 398-406.